NCT04231630 is a NA clinical trial of Prolacta in Growth Delay, sponsored by University of Texas at Austin.

Who is sponsoring NCT04231630?

NCT04231630 is sponsored by University of Texas at Austin.

What drugs are being tested in NCT04231630?

Interventions in NCT04231630: Prolacta.

What condition does NCT04231630 study?

NCT04231630 studies Growth Delay.

Is NCT04231630 still recruiting?

NCT04231630 is currently status unknown. Last updated 18 January 2020.

Last reviewed 2020-01-18 · How we verify

NCT04231630

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outpatient Exclusive Human Milk Diet for Single Infant With Complex Congenital Heart Disease

Status unknown NA Last updated 18 January 2020

What this trial tests

NA trial testing Prolacta in Growth Delay in 1 participant. Status unknown.

Timeline

20 November 2019

Primary endpoint
30 April 2020

30 May 2020

Quick facts

Lead sponsor	University of Texas at Austin
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	1
Start date	20 November 2019
Primary completion	30 April 2020
Estimated completion	30 May 2020
Sites	1 location across United States

Drugs / interventions tested

Prolacta

Conditions studied

Growth Delay — all drugs for Growth Delay →

Sponsor

University of Texas at Austin

Who can join

Adults 6 Months to 1, male only, with Growth Delay. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A single patient observational trial to evaluate growth velocity and clinical outcomes of an infant status post cardiac surgery who has failed to grow well and demonstrated intolerance to cow milk-based and elemental formulas and fortifiers on a 100% human milk diet including a human milk based human milk fortifier formulated for term infants fluid restricted due to surgically correctable congenital conditions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Growth Delay

Currently open trials in the same condition.

NCT06931912 — Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia · NA · recruiting
NCT05990582 — The Alkmaar MLPTI Cohort Study: Outcomes at 9 Years · NA · active not recruiting

Other University of Texas at Austin trials

Trials by the same sponsor.

NCT07319234 — Development of MENU Protocol · NA · not yet recruiting
NCT07480109 — Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) · NA · not yet recruiting
NCT07069413 — Sibwatch: Optimizing Intervention Options for Infants and Toddler Siblings of Autistic Children · NA · not yet recruiting
NCT07370311 — A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisi · NA · not yet recruiting
NCT07441122 — Enhancing Attention in Elderly Using a Brain-Computer-Interface · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04231630 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Texas at Austin
Last refreshed: 18 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04231630.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing